Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-80
SponsorSMG-SNU Boramae Medical Center
About this trial
The efficacy of electrosurgical bipolar systems in axillary lymph node dissection for breast cancer surgery is well known. In this study, the investigators aim to determine whether using electrosurgical bipolar systems helps reduce seroma formation in high-risk patients undergoing sentinel lymph node biopsy (SLNB) for breast cancer surgery. The investigators will focus on patients who are expected to experience high drainage output after SLNB, especially those who are obese (BMI\>25) or have undergone preoperative chemotherapy.
Eligibility criteria
Qualifiers
Women aged 20-80
Candidates for breast-conserving surgery and axillary sentinel lymph node biopsy
BMI over 25 or those who have received preoperative chemotherapy
Overall performance status of Eastern Cooperative Oncology Group (ECOG) 0-2
Disqualifiers
Those with suspected axillary lymph node enlargement or metastasis on preoperative imaging (breast MRI, chest CT, breast ultrasound)
Among patients who had confirmed lymph node metastasis before neoadjuvant chemotherapy, whose preopreative image showed residual disease at axillary lymph node
Those planning for mastectomy
Those planning for axillary lymph node dissection without SLNBx
Trial design
Treatments tested in this trial
- Electrosurgical bipolar system (LigaSure)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov